COSMOS Pharmaceutical (TSE:3349) EV-to-EBITDA : 16.64 (As of May. 07, 2024)

COSMOS Pharmaceutical EV-to-EBITDA Chart

COSMOS Pharmaceutical Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	May23
EV-to-EBITDA		Get a 7-Day Free Trial					8.33	13.00	10.65	9.44	9.91

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-EBITDA	Get a 7-Day Free Trial															14.46	9.91	19.58	18.07	16.55

Competitive Comparison of COSMOS Pharmaceutical's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

COSMOS Pharmaceutical's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's EV-to-EBITDA falls into.

COSMOS Pharmaceutical EV-to-EBITDA Calculation

COSMOS Pharmaceutical's EV-to-EBITDA for today is calculated as:

COSMOS Pharmaceutical's current Enterprise Value is 円574,797 Mil.
COSMOS Pharmaceutical's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円34,553 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

COSMOS Pharmaceutical  (TSE:3349) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

COSMOS Pharmaceutical's PE Ratio for today is calculated as:

COSMOS Pharmaceutical's share price for today is 円14700.00.
COSMOS Pharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円627.871.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

COSMOS Pharmaceutical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

COSMOS Pharmaceutical (TSE:3349) Business Description